Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2021 7
2022 8
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean li shuo shi (2 results)?
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
Hu H, Kang L, Zhang J, Wu Z, Wang H, Huang M, Lan P, Wu X, Wang C, Cao W, Hu J, Huang Y, Huang L, Wang H, Shi L, Cai Y, Shen C, Ling J, Xie X, Cai Y, He X, Dou R, Zhou J, Ma T, Zhang X, Luo S, Deng W, Ling L, Liu H, Deng Y. Hu H, et al. Among authors: shi l. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):38-48. doi: 10.1016/S2468-1253(21)00348-4. Epub 2021 Oct 22. Lancet Gastroenterol Hepatol. 2022. PMID: 34688374 Clinical Trial.
Gastrointestinal cancers in China, the USA, and Europe.
Xie Y, Shi L, He X, Luo Y. Xie Y, et al. Among authors: shi l. Gastroenterol Rep (Oxf). 2021 Mar 29;9(2):91-104. doi: 10.1093/gastro/goab010. eCollection 2021 Apr. Gastroenterol Rep (Oxf). 2021. PMID: 34026216 Free PMC article. Review.
Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort study.
Yang H, Huang Z, Li M, Zhang H, Fu L, Wang X, Yang Q, He Y, Wu W, Jiang T, Sun Z, Zhang T, Lai D, Wu X, Shi L, Guo Q, Wu Y, Tang J, Chao K, Gao X. Yang H, et al. Among authors: shi l. EClinicalMedicine. 2023 Dec 2;66:102337. doi: 10.1016/j.eclinm.2023.102337. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38089859 Free PMC article.
China special issue on gastrointestinal tumors-Radiological features of pathological complete response in mismatch repair deficient colorectal cancer after neoadjuvant PD-1 blockade: A post hoc analysis of the PICC phase II trial.
Cao W, Hu H, Li J, Wu Q, Shi L, Li B, Zhou J, Wang X, Chen J, Wang C, Wang H, Deng W, Huang Y, Deng Y. Cao W, et al. Among authors: shi l. Int J Cancer. 2023 Dec 1;153(11):1894-1903. doi: 10.1002/ijc.34647. Epub 2023 Jul 6. Int J Cancer. 2023. PMID: 37409565 Clinical Trial.
23 results